Sutton Wealth Advisors Inc. Biogen Inc. Transaction History

Sutton Wealth Advisors Inc.

  • $203 Billion
  • Q3 2023

A detailed history of Sutton Wealth Advisors Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Sutton Wealth Advisors Inc. holds 33 shares of BIIB stock, worth $5,735. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33
Previous 23 43.48%
Holding current value
$5,735
Previous $6.55 Million 29.44%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023
BUY
$253.3 - $285.89 $2,533 - $2,858
10 Added 43.48%
33 $8.48 Million
Q2 2023

Nov 08, 2023
SELL
$275.25 - $318.06 $825 - $954
-3 Reduced 11.54%
23 $6.55 Million
Q1 2023

Nov 07, 2023
SELL
$256.56 - $292.34 $215,510 - $245,565
-840 Reduced 97.0%
26 $7.23 Million
Q4 2022

Nov 07, 2023
BUY
$252.44 - $306.72 $1,514 - $1,840
6 Added 0.7%
866 $240 Million
Q3 2022

Nov 07, 2023
SELL
$194.69 - $268.46 $2,530 - $3,489
-13 Reduced 1.49%
860 $230 Million
Q2 2022

Nov 07, 2023
SELL
$187.54 - $223.02 $4,876 - $5,798
-26 Reduced 2.89%
873 $178 Million
Q1 2022

Nov 07, 2023
BUY
$193.77 - $244.14 $2,519 - $3,173
13 Added 1.47%
899 $189 Million
Q4 2021

Nov 07, 2023
SELL
$223.92 - $287.77 $1,119 - $1,438
-5 Reduced 0.56%
886 $213 Million
Q3 2021

Nov 07, 2023
SELL
$282.99 - $369.05 $565 - $738
-2 Reduced 0.22%
891 $252 Million
Q2 2021

Nov 07, 2023
BUY
$259.0 - $414.71 $777 - $1,244
3 Added 0.34%
893 $309 Million
Q1 2021

Nov 07, 2023
BUY
$242.95 - $284.63 $971 - $1,138
4 Added 0.45%
890 $249 Million
Q4 2020

Nov 07, 2023
BUY
$236.26 - $355.63 $708 - $1,066
3 Added 0.34%
886 $217 Million
Q3 2020

Nov 07, 2023
SELL
$264.77 - $305.71 $264 - $305
-1 Reduced 0.11%
883 $250 Million
Q2 2020

Nov 07, 2023
BUY
$258.66 - $342.55 $775 - $1,027
3 Added 0.34%
884 $237 Million
Q1 2020

Nov 07, 2023
BUY
$268.85 - $341.04 $806 - $1,023
3 Added 0.34%
881 $279 Million
Q2 2019

Nov 06, 2023
SELL
$219.29 - $241.72 $657 - $725
-3 Reduced 0.34%
878 $205 Million
Q1 2019

Nov 06, 2023
BUY
$216.71 - $338.96 $866 - $1,355
4 Added 0.46%
881 $208 Million
Q2 2017

Nov 06, 2023
BUY
N/A
5 Added 0.57%
877 $238 Million
Q1 2017

Nov 06, 2023
SELL
N/A
-5 Reduced 0.57%
872 $238 Million
Q4 2016

Nov 06, 2023
BUY
N/A
3 Added 0.34%
877 $249 Million
Q3 2016

Nov 06, 2023
BUY
N/A
5 Added 0.58%
874 $274 Million
Q2 2016

Nov 06, 2023
BUY
N/A
3 Added 0.35%
869 $210 Million
Q1 2016

Nov 06, 2023
BUY
N/A
866
866 $225 Million

Others Institutions Holding BIIB

# of Institutions
1,018
Shares Held
128M
Call Options Held
1.22M
Put Options Held
1.4M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Sutton Wealth Advisors Inc. Portfolio

Follow Sutton Wealth Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sutton Wealth Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sutton Wealth Advisors Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email